Drug-induced or toxic liver disease with cholestasis (Q43595): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/1947902215
@@ Property / Canonical URI: https://id.who.int/icd/entity/1947902215 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:DB95.2
@@ Property / CURIE: CID11:DB95.2 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-DB95.2
@@ Property / Canary Token: dki-india-DB95.2 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+K71.0
@@ Property / Linked ICD 10: K71.0 / rank @@
+Normal rank

Latest revision as of 10:40, 13 August 2026

This is a drug-induced cholestatic liver injury where the symptoms of pruritus and jaundice are often prominent, and elevated serum alkaline phosphatase is the dominant biochemical finding.

Language	Label	Description	Also known as
default for all languages	DB95.2
English	Drug-induced or toxic liver disease with cholestasis	This is a drug-induced cholestatic liver injury where the symptoms of pruritus and jaundice are often prominent, and elevated serum alkaline phosphatase is the dominant biochemical finding.